Elentior Pharmaceuticals Private Limited
About Elentior Pharmaceuticals Private Limited
Data last updated:
Elentior Pharmaceuticals Private Limited was a private limited company based in Navi Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the service-based operations segment of the services sector. It was incorporated on 13 February 2019.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U93090MH2019PTC321145. Its GSTIN is 27AAFCE3754P1Z3 (Maharashtra).
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Kumarasamy Nirmala and Thiagarajan.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at 404 Anant Aura Sector 26 Taloja Phase II, Navi Mumbai, Maharashtra, India – 410208.
Company details
Contact details
Elentior Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address404 Anant Aura Sector 26 Taloja Phase II, Navi Mumbai, Maharashtra, India – 410208
- IndustryService, Other Services
To see the full contact details of Elentior Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Elentior Pharmaceuticals Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Elentior Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elentior Pharmaceuticals Private Limited
Elentior Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumarasamy Nirmala | Director | 13 Feb 2019 | 7 Years 8 Months | As last reported |
| Thiagarajan | Director | 13 Feb 2019 | 7 Years 8 Months | As last reported |
Legal cases
No court or tribunal cases involving Elentior Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elentior Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elentior Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCE3754P1Z3 | Maharashtra | Active | 19 Mar 2019 |
To see the full GST registrations and return filing status of Elentior Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elentior Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Subramani Lakshmi ceased to be Director on 29 Jun 2020.
Frequently asked questions
Elentior Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Elentior Pharmaceuticals was a private limited company based in Navi Mumbai, Maharashtra, India. The company worked in other services, within the service industry. It was incorporated on 13 February 2019 and is registered under CIN U93090MH2019PTC321145. The company has been struck off by the Registrar of Companies and is no longer operational.
Elentior Pharmaceuticals had 2 directors:
- Kumarasamy Nirmala - Director
- Thiagarajan - Director
The CIN (Corporate Identification Number) of Elentior Pharmaceuticals is U93090MH2019PTC321145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Elentior Pharmaceuticals is at 404 Anant Aura Sector 26 Taloja Phase II, Navi Mumbai, Maharashtra, India – 410208.
Elentior Pharmaceuticals was incorporated on 13 February 2019. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Elentior Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Elentior Pharmaceuticals is 27AAFCE3754P1Z3, registered in Maharashtra.
Elentior Pharmaceuticals operated in the service industry, in the other services segment. It worked in this industry before it was struck off.
Subramani Lakshmi ceased to be Director on 29 Jun 2020. Kumarasamy Nirmala was appointed as Director on 13 Feb 2019. Thiagarajan was appointed as Director on 13 Feb 2019.